87922-29-0 Usage
Uses
Used in Pharmaceutical Research:
2,3-dimethoxy-6-methyl-8,9-(methylenedioxy)-11H-indeno(1,2-c)isoquinoline is used as a research compound for its potential pharmacological properties. Its unique molecular structure and functional groups may contribute to the development of new drugs and therapeutic agents.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 2,3-dimethoxy-6-methyl-8,9-(methylenedioxy)-11H-indeno(1,2-c)isoquinoline is utilized as a starting material or intermediate in the synthesis of novel compounds with potential therapeutic applications.
Used in Drug Discovery:
2,3-dimethoxy-6-methyl-8,9-(methylenedioxy)-11H-indeno(1,2-c)isoquinoline is employed as a lead compound in drug discovery processes, where its structure and properties are investigated for the development of new pharmaceuticals.
Used in Chemical Synthesis:
2,3-dimethoxy-6-methyl-8,9-(methylenedioxy)-11H-indeno(1,2-c)isoquinoline is used as a target in chemical synthesis, where its unique structural characteristics are exploited to develop new synthetic methodologies and improve existing ones.
Used in Development of New Synthetic Methodologies:
2,3-dimethoxy-6-methyl-8,9-(methylenedioxy)-11H-indeno(1,2-c)isoquinoline is utilized in the research and development of innovative synthetic approaches, potentially leading to more efficient and selective chemical reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 87922-29-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,7,9,2 and 2 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 87922-29:
(7*8)+(6*7)+(5*9)+(4*2)+(3*2)+(2*2)+(1*9)=170
170 % 10 = 0
So 87922-29-0 is a valid CAS Registry Number.
InChI:InChI=1/C20H18NO4.ClH/c1-21-9-12-6-16(22-2)17(23-3)7-13(12)15-4-11-5-18-19(25-10-24-18)8-14(11)20(15)21;/h5-9H,4,10H2,1-3H3;1H/q+1;/p-1
87922-29-0Relevant academic research and scientific papers
Synthesis and biological activity of structural analogues of the anticancer benzophenanthridine alkaloid nitidine chloride
Cushman,Mohan,Smith
, p. 544 - 547 (2007/10/02)
The indenoisoquinoline analogue 9 of nitidine (1) has been prepared and found to possess significant anticancer activity against L1210 lymphoid leukemia, P388 lymphocytic leukemia, and B16 melanocarcinoma. Analogue 14, which lacks the B ring of nitidine (1), has also been synthesized. Compound 14 retains the in vitro toxicity associated with nitidine (1) but is devoid of antileukemic activity. The structural factors that may contribute to the difference in biological activity between the two closely related analogues 9 and 14 are discussed.
